Ultralife Corporation Files Form 12b-25 Notification of Late Filing
Rhea-AI Summary
Ultralife (NASDAQ: ULBI) has filed a Form 12b-25 with the SEC, notifying a delay in submitting its Annual Report on Form 10-K for fiscal year 2024. The delay is attributed to the ongoing completion of accounting close and financial results audit of Electrochem Solutions, Inc., which was acquired on October 31, 2024.
The company expects to file its Form 10-K no later than April 1, 2025. Consequently, Ultralife will reschedule its previously planned fourth quarter and fiscal year 2024 earnings release and conference call from March 11, 2025. The new date will be announced once the Form 10-K filing date is confirmed.
Positive
- Company complying with SEC regulations by filing Form 12b-25
- Recent acquisition of Electrochem Solutions expands business portfolio
Negative
- Delay in filing annual 10-K report indicates potential accounting complexities
- Postponement of Q4 and FY2024 earnings release creates uncertainty
News Market Reaction
On the day this news was published, ULBI declined 3.47%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEWARK, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI), today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
The extension is necessary to allow for the completion of the accounting close and financial results audit of Electrochem Solutions, Inc., which the Company acquired on October 31, 2024. The Company expects to file its Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than April 1, 2025, in accordance with Rule 12b-25.
In addition, the Company will reschedule its earnings release and conference call for the fourth quarter and fiscal year 2024, previously scheduled for Tuesday, March 11, 2025, and announce the date and time of the rescheduled earnings release and call once the filing date of its Form 10-K is confirmed.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.
| Company Contact: Ultralife Corporation Philip A. Fain (315) 210-6110 pfain@ulbi.com | Investor Relations Contact: Alliance Advisors IR Jody Burfening/Alex Villalta (212) 838-3777 avillalta@allianceadvisors.com |
FAQ
Why is Ultralife (ULBI) delaying its 2024 Form 10-K filing?
When will Ultralife (ULBI) file its delayed 2024 Form 10-K?
What impact does the Form 12b-25 filing have on ULBI's earnings release?
When did ULBI acquire Electrochem Solutions, Inc.?
